Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system.
Peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-dependent transcription factor involved in many aspects of metabolism, immune response, and development. Total-body deletion of the two Pparg alleles provoked generalized lipoatrophy along with severe type 2 diabetes. Herein, we explor...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5300244?pdf=render |
_version_ | 1819060386359410688 |
---|---|
author | Barbara Toffoli Federica Gilardi Carine Winkler Magnus Soderberg Laura Kowalczuk Yvan Arsenijevic Krister Bamberg Olivier Bonny Béatrice Desvergne |
author_facet | Barbara Toffoli Federica Gilardi Carine Winkler Magnus Soderberg Laura Kowalczuk Yvan Arsenijevic Krister Bamberg Olivier Bonny Béatrice Desvergne |
author_sort | Barbara Toffoli |
collection | DOAJ |
description | Peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-dependent transcription factor involved in many aspects of metabolism, immune response, and development. Total-body deletion of the two Pparg alleles provoked generalized lipoatrophy along with severe type 2 diabetes. Herein, we explore the appearance and development of structural and functional alterations of the kidney, comparing Pparg null-mice to their littermate controls (carrying Pparg floxed alleles). We show that renal hypertrophy and functional alterations with increased glucosuria and albuminuria are already present in 3 weeks-old Pparg null-mice. Renal insufficiency with decreased creatinine clearance progress at 7 weeks of age, with the advance of the type 2 diabetes. At 52 weeks of age, these alterations are accompanied by signs of fibrosis and mesangial expansion. More intriguingly, aged Pparg null-mice concomitantly present an anti-phospholipid syndrome (APS), characterized by the late appearance of microthrombi and a mesangioproliferative pattern of glomerular injury, associated with significant plasmatic levels of anti-β2- glycoprotein1 antibodies and renal deposition of IgG, IgM, and C3. Thus, in line with the role of PPARγ in metabolic homeostasis, Pparg null-mice first represent a potent model for studying the initiation and the development of diabetic nephropathy. Second, and in relation with the important PPARγ activity in inflammation and in immune system, these mice also highlight a new role for PPARγ signaling in the promotion of APS, a syndrome whose pathogenesis is poorly known and whose current treatment is limited to prevention of thrombosis events. |
first_indexed | 2024-12-21T14:26:10Z |
format | Article |
id | doaj.art-4ff6c1385d6148348a565d93def9243d |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-21T14:26:10Z |
publishDate | 2017-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-4ff6c1385d6148348a565d93def9243d2022-12-21T19:00:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017147410.1371/journal.pone.0171474Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system.Barbara ToffoliFederica GilardiCarine WinklerMagnus SoderbergLaura KowalczukYvan ArsenijevicKrister BambergOlivier BonnyBéatrice DesvergnePeroxisome proliferator-activated receptor γ (PPARγ) is a ligand-dependent transcription factor involved in many aspects of metabolism, immune response, and development. Total-body deletion of the two Pparg alleles provoked generalized lipoatrophy along with severe type 2 diabetes. Herein, we explore the appearance and development of structural and functional alterations of the kidney, comparing Pparg null-mice to their littermate controls (carrying Pparg floxed alleles). We show that renal hypertrophy and functional alterations with increased glucosuria and albuminuria are already present in 3 weeks-old Pparg null-mice. Renal insufficiency with decreased creatinine clearance progress at 7 weeks of age, with the advance of the type 2 diabetes. At 52 weeks of age, these alterations are accompanied by signs of fibrosis and mesangial expansion. More intriguingly, aged Pparg null-mice concomitantly present an anti-phospholipid syndrome (APS), characterized by the late appearance of microthrombi and a mesangioproliferative pattern of glomerular injury, associated with significant plasmatic levels of anti-β2- glycoprotein1 antibodies and renal deposition of IgG, IgM, and C3. Thus, in line with the role of PPARγ in metabolic homeostasis, Pparg null-mice first represent a potent model for studying the initiation and the development of diabetic nephropathy. Second, and in relation with the important PPARγ activity in inflammation and in immune system, these mice also highlight a new role for PPARγ signaling in the promotion of APS, a syndrome whose pathogenesis is poorly known and whose current treatment is limited to prevention of thrombosis events.http://europepmc.org/articles/PMC5300244?pdf=render |
spellingShingle | Barbara Toffoli Federica Gilardi Carine Winkler Magnus Soderberg Laura Kowalczuk Yvan Arsenijevic Krister Bamberg Olivier Bonny Béatrice Desvergne Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. PLoS ONE |
title | Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. |
title_full | Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. |
title_fullStr | Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. |
title_full_unstemmed | Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. |
title_short | Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. |
title_sort | nephropathy in pparg null mice highlights pparγ systemic activities in metabolism and in the immune system |
url | http://europepmc.org/articles/PMC5300244?pdf=render |
work_keys_str_mv | AT barbaratoffoli nephropathyinppargnullmicehighlightsppargsystemicactivitiesinmetabolismandintheimmunesystem AT federicagilardi nephropathyinppargnullmicehighlightsppargsystemicactivitiesinmetabolismandintheimmunesystem AT carinewinkler nephropathyinppargnullmicehighlightsppargsystemicactivitiesinmetabolismandintheimmunesystem AT magnussoderberg nephropathyinppargnullmicehighlightsppargsystemicactivitiesinmetabolismandintheimmunesystem AT laurakowalczuk nephropathyinppargnullmicehighlightsppargsystemicactivitiesinmetabolismandintheimmunesystem AT yvanarsenijevic nephropathyinppargnullmicehighlightsppargsystemicactivitiesinmetabolismandintheimmunesystem AT kristerbamberg nephropathyinppargnullmicehighlightsppargsystemicactivitiesinmetabolismandintheimmunesystem AT olivierbonny nephropathyinppargnullmicehighlightsppargsystemicactivitiesinmetabolismandintheimmunesystem AT beatricedesvergne nephropathyinppargnullmicehighlightsppargsystemicactivitiesinmetabolismandintheimmunesystem |